SLE
Clinical trials for SLE explained in plain language.
Never miss a new study
Get alerted when new SLE trials appear
Sign up with your email to follow new studies for SLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Living Drug' to reset immune system in 8 serious diseases
Disease control TerminatedThis early-phase study aimed to test a new type of cell therapy for people with serious autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis. The therapy, called CAR-T, involves modifying a patient's own immune cells to target and remove the cells causing the…
Matched conditions: SLE
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Off-the-Shelf immune cell therapy tested for stubborn lupus
Disease control OngoingThis early-stage trial is testing a new cell therapy called AB-101 for adults with severe lupus or lupus-related kidney disease that hasn't improved with standard treatments. The therapy uses donated 'natural killer' immune cells, given alone or alongside antibody drugs, to try t…
Matched conditions: SLE
Phase: PHASE1 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Hidden heart damage in lupus flares?
Knowledge-focused OngoingThis study aims to understand if lupus flares cause hidden inflammation in the heart muscle. Researchers will use special heart scans (MRI) on 40 people with lupus during a flare and again 3 months later to look for signs of swelling. The goal is to learn more about why people wi…
Matched conditions: SLE
Sponsor: Stacy Ardoin MD • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC